AUA 2013 - Poster: Safety and changes in laboratory parameters associated with sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC): Phase 2 ProACT study

SAN DIEGO, CA USA (UroToday.com) - Presented by Thomas Gardner,1 Daniel Petrylak,2 John Corman,3 Simon Hail,4 Ralph Weinstein,5 Robert Sims,6 Todd DeVries,6 and Celestia Higano7 at the American Urological Association (AUA) Annual Meeting - May 4 - 8, 2013 - San Diego Convention Center - San Diego, California USA

 

Safety and Changes in Lab Parameters Associated with sip-T in Patients with mCRPC thumb

 

1Urology Indiana University Health, Indianapolis, IN, USA; 2Yale Cancer Center, New Haven, CT, USA; 3Virginia Mason Medical Center, Seattle, WA, USA; 4Mount Sinai School of Medicine, New York, NY, USA; 5US Oncology, Portland, OR, USA; 6Dendreon Corporation, Seattle, WA, USA; 7School of Medicine, University of Washington, Seattle, WA, USA

aua

View Full AUA 2013 Coverage

 

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe